Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
Merck Sharp & Dohme LLC
Kohei Shitara; Sylvie Lorenzen; Jin Li; Yuxian Bai; Manuel González Fernández; Mynor Aguilar; Hirokazu Shoji; Felipe Reyes-Cosmelli; Yovany Rodriguez Peña; Luis Corrales; Lucjan Wyrwicz; Daniel Acosta Eyzaguirre; Yueyin Pan; Min-Hee Ryu; Deirdre J Cohen; Zev A Wainberg; Geoffrey Ku; Josep Tabernero; Eric Van Cutsem; Shu-Kui Qin; Do-Youn Oh; Jianming Xu; Li Wen Liang; Sonal Bordia; Pooja Bhagia; Sun Young Rha; LEAP-015 Investigators